More aggressive marketing ∝ 1/benefit-to-harm ratio

New “Law” Attempts to Explain Strategies Drug Marketers Use to Sway Prescribing, March 16, 2011, Mitka 305 (11): 1083 — JAMA

An interesting and concise new article on the influence of marketing on prescribing patterns was published online in the American Journal of Public Health and then picked up in the commentary of JAMA. It is an interesting read and does a good job of describing one of the bigger problems in the translation of evidence into practice.

from JAMA

[a picture from the JAMA commentary]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s